Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ecstasy-Assisted therapy shows promise for veterans haunted by war

NCT ID NCT05732155

Recruiting now Disease control Sponsor: HaEmek Medical Center, Israel Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study explores whether MDMA (ecstasy) combined with talk therapy can help Israeli special forces veterans suffering from PTSD and moral injury. Participants receive a flexible dose of MDMA in either individual or group therapy sessions. The goal is to measure changes in PTSD symptoms and safety over the course of treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MDMA (also known as ecstasy)
What this could lead to
If successful, this could point toward an effective therapy for PTSD and moral injury in veterans, potentially reducing symptoms and improving quality of life.
What could go wrong
This is a small, early-phase study with no placebo group, so results may not be conclusive. MDMA can cause side effects like anxiety, increased heart rate, and emotional distress during sessions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MDMA ('ECSTASY') are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MDMA ('ECSTASY') MORAL INJURY POST-TRAUMATIC STRESS DISORDER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emek medical center

    RECRUITING

    Afula, 1910500, Israel

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.